Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 139
Infectious Diseases Drugs 90
Endocrine and Metabolic Disorders Drugs 83
Drug Discovery 79
Central Nervous System Drugs 69
Immune Disorders Drugs 68
Genomics 60
Clinical Trials 51
Diabetes Drugs 45
Prostate Cancer Drugs 44
Pharmaceuticals 43
Biopharmaceuticals 41
Dermatological Drugs 39
Vaccines 38
Women's Health 33
Urological Disorders Drugs 33
Cardiovascular Drugs 32
Gastrointestinal Drugs 30
Liver and Kidney Disorders Drugs 29
Musculoskeletal Disorders Drugs 29
Biotechnology 28
Enzymes 26
Optical Disorders Drugs 24
Leukemia Drugs 23
Immunosuppressive Drugs 23
Stem Cells 22
Sexual and Reproductive Health Drugs 22
Antibiotics 20
Allergy and Immunology 19
Analgesics 18
Oncology 16
Lung Cancer Drugs 15
Diagnostics 15
Drug Delivery 14
Surgical Procedures 14
Optical 13
Infusions and Injectables 11
Medical Devices 11
Urology and Nephrology 10
Bladder Cancer Drugs 10
Dermatology 10
Respiratory Drugs 10
Pharmaceutical Manufacturing 10
Healthcare Services 9
Hematological Drugs 9
Therapeutic Area 8
Neurology 8
Kidney Cancer Drugs 8
Lymphoma Drugs 7
Managed Care 7
Hearing Aids and Implants 7
Hematology 7
Pancreatic Cancer Drugs 7
Gastroenterology 7
Allergy Drugs 7
Mental Disorders Drugs 6
Pharmaceutical Intermediates 5
Pulmonary Medicine 5
Proteomics 5
Biomaterials 5
Needles and Syringes 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
In Vitro Diagnostics 4
Infectious Disease Testing 4
Diabetes Devices 4
Over the Counter (OTC) Drugs 4
Cancer Vaccines 4
Skin Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Colon Cancer Drugs 3
Glucose Testing 3
Transdermal and Transmucosal Drug Delivery 3
Mental Health 3
Pediatrics 3
Addiction Disorders Drugs 2
Drugs by Therapeutic Area 2
Liver Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Biomarkers 2
Surgical Devices 2
Nuclear Medicine and Radiopharmacology 2
Thyroid Cancer Drugs 2
Alzheimer's Disease Drugs 2
Asthma Drugs 2
Psoriasis Drugs 2
Patient Monitoring Equipment 1
Medical Plastics 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Stents 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Palliative Care 1
Anatomy 1
Cardiology 1
Acne Drugs 1
Schizophrenia Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

1,191 Results (Page 45 of 60)
- Relevance
  Sort by

Interleukin Inhibitors Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

toxoplasmosis Treatment Drugs Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Systemic Aspergillosis and Systemic Candidiasis Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Nontuberculous Mycobacterial Infection Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Aspergillosis Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Anti-Inflammatory Therapeutics Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Menopause - Market Insights, Epidemiology and Market Forecast - 2032

 Report
November 2023
188 Pages
Global

From

€5185EUR$5,250USD£4,314GBP

€7407EUR$7,500USD£6,163GBP

Candidiasis Therapeutics Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

Drug Discovery Market by Drug Type, Technology, Therapeutic Area, End User - Global Forecast 2025-2030

 Report
October 2024
197 Pages
Global

From

€3501EUR$3,545USD£2,913GBP

€3890EUR$3,939USD£3,237GBP

14-alpha demethylase inhibitors - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€1037EUR$1,050USD£863GBP

€1481EUR$1,500USD£1,233GBP

Next-Generation Immunology Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

 Report
April 2023
130 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

South Africa Oral Antidiabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
South Africa

From

€4691EUR$4,750USD£3,903GBP

Antifungals Global Market Report 2024

 Report
November 2023
175 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Preventive Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
95 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Oral Anti-Diabetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
150 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

Japan Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Japan

From

€4691EUR$4,750USD£3,903GBP

Italy Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Italy

From

€4691EUR$4,750USD£3,903GBP

India Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
India

From

€4691EUR$4,750USD£3,903GBP

New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4691EUR$4,750USD£3,903GBP

1,191 Results (Page 45 of 60)
- 1
- 43
- 44
- 45
- 46
- 47

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.